You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Extended Release of Pyridostigmine Bromide for Effectively Combating Nerve Agent Exposure
SBC: INNOSENSE CORPORATION Topic: CBD181004Chemical warfare agents such as the lethal nerve agent soman are a major source of risk to military personnel. Currently, pyridostigmine bromide (PB) is the only FDA-approved pretreatment to counteract the effects of soman. The rationale behind PB administration is that it acts as a “temporary” inhibitor of AChE. This precludes nerve agents from irreversible inactivation of AChE, thereby mitig ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Dual Formulation of Atropine/Scopolamine with Enhanced Stability
SBC: CMC PHARMACEUTICALS INC Topic: CBD181005CMC Pharmaceuticals, Inc. (Cleveland, OH) is proposing developing a stable, combination product of two small molecule drug candidates as a counter measure to chemical warfare nerve agents (NA). The combination product is expected to exploit complementary pharmacological profiles for optimal muscarinic receptor blockade and anticholinergic activity within the peripheral and central nervous system. ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Sequential Phase II Proposal for Smartphone Application for Mask Sizing and Projecting Quantitative Fit
SBC: Physical Optics Corporation Topic: CBD181006To address the Chemical and Biological Defense (CBD) need for a field-portable mass spectrometer for small molecule drugs in clinical samples, Physical Optics Corporation (POC) proposes to develop a new FiEldable DRug Mass Analysis (FERMA) system based on a combination of portable mass spectrometry technology with laser desorption/ionization for use with aqueous clinical samples. The FERMA system ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Field Portable Mass Spectrometry for Small Molecule Drugs in Clinical Samples
SBC: SPECTRAL ENERGIES LLC Topic: CBD181006We propose a novel two-dimensional mass spectrometry (2D-MS) technique based on ion trap arrays to identify illicit and designer drugs. This approach will give an unprecedented multiplex advantage for miniature mass spectrometry, allowing novice field technicians to rapidly identify drugs affecting the central nervous system based on both the m/z ratio and fragmentation pattern of an ion. Towards ...
SBIR Phase I 2019 Department of DefenseOffice for Chemical and Biological Defense -
Ocular Penetrating/Perforating injuries Assessment Hydrogel system (OPPAH)
SBC: CHROMOLOGIC LLC Topic: DHA182004In order to meet Defense Health Agency’s need for rapid confirmation and evaluation of open globe injuries, to allow for appropriate initial triage, evacuation, and treatments, ChromoLogic LLC (CL) proposes to develop an Ocular Penetrating/Perforating inj
SBIR Phase I 2019 Department of DefenseDefense Health Agency -
Cervical Spine Health Improvement Products
SBC: SWITCHBOX INC Topic: DHA18B001Most standard-of-care tools and techniques for evaluating neck disorders are subjective, unreliable, and do not provide actionable information for providers, payers, and organizations to deliver efficient and effective care. This lack of objective neck he
STTR Phase I 2019 Department of DefenseDefense Health Agency -
Augmented Reality Surgical Visualization
SBC: CFD RESEARCH CORPORATION Topic: DHA191001Care for the wounded Warfighters in austere and remote settings makes medical knowledge, skills and efficiency of the military medical professional paramount. For wounds that extend deep into internal anatomy, proper visualization of internal anatomy can
SBIR Phase I 2019 Department of DefenseDefense Health Agency -
Augmented Reality Surgical Visualization Tool for Combat Casualty Care
SBC: NAKAMIR INC Topic: DHA191001We propose development of an AR system that allows the medical personnel to visualize the internal anatomy of a patient by projecting relevant anatomical information onto the patient directly into the field of view (FOV) of the medic. With no medical imag
SBIR Phase I 2019 Department of DefenseDefense Health Agency -
The Medic’s Enhanced Diagnostic Imaging Companion (MEDIC) System
SBC: AUGMNTR, INC. Topic: DHA191001The purpose of the MEDIC (Medic’s Enhanced Diagnostic Imaging Companion) system is to provide combat medics, via Augmented Reality (AR), a digitally-superimposed avatar representing the internal anatomy of their Warfighter patient. Phase I of this SBIR p
SBIR Phase I 2019 Department of DefenseDefense Health Agency -
Advanced Simulated Patient Intelligent Response Engine (ASPIRE)
SBC: VCOM3D INC Topic: DHA191002The goal of medical simulation-based training such as high-fidelity manikin simulators, part task trainers, and screen-based virtual patients, is to approximate real-life treatment experiences without risk to live patients. While the use of sensors has ma
SBIR Phase I 2019 Department of DefenseDefense Health Agency